Human papillomavirus testing for cervical screening
Medical Services Advisory Committee
Record ID 32004000015
English
Authors' objectives:
This report reviews the evaluation of detection of high-risk human papillomavirus (HPV) subtypes by the Hybrid Capture-II (HC-II) test for routine cervical screening either as a stand-alone test or as an adjunct to the conventional Pap or liquid-based smear.
Authors' recommendations:
Since there is currently insufficient evidence pertaining to HPV testing for cervical screening, the MSAC recommended that public funding should not be supported at this time for this screening test.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.msac.gov.au/reports.htm
Year Published:
2003
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Costs and Cost Analysis
- Vaginal Smears
- Carcinoma
- Papillomavirus Infections
- Tumor Virus Infections
Contact
Organisation Name:
Medical Services Advisory Committee
Contact Address:
MSAC (MDP 107), GPO Box 9848, Canberra, ACT 2601, Australia. Tel: +61 2 6289 6811; Fax: +61 2 6289 8799.
Contact Name:
msac.secretariat@health.gov.au
Contact Email:
msac.secretariat@health.gov.au
Copyright:
Medical Services Advisory Committee (MSAC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.